Digestive cancer incidence and mortality among young adults worldwide in 2020: A population-based study

Abstract

BACKGROUND Digestive cancer has traditionally been thought of as a disease that mainly occurs in elderly individuals, and it has been ignored in young adults by both patients and physicians. AIM To describe the worldwide profile of digestive cancer incidence, mortality and corresponding trends among 20–39-year-olds, with major patterns highlighted by age, sex, development level, and geographical region. METHODS I performed a population-based study to quantify the burden of young adult digestive cancers worldwide. Global, regional, sex, and country-specific data estimates of the number of new cancer cases and cancer-associated deaths that occurred in 2020 were extracted from the GLOBOCAN Cancer Today database. To assess long-term trends in young adult digestive cancer, cancer incidence data and mortality data were obtained from the Cancer in Five Continents Plus database and the World Health Organization mortality database, respectively. The associations between the human development index (HDI) and digestive cancer burden in young adults were evaluated by linear regression analyses. RESULTS In 2020, there were an estimated 19292789 new cancer cases, resulting in 9958133 deaths worldwide, which equated to an age-standardized incidence rate (ASIR) of 5.16 and age-standardized mortality rate (ASMR) of 3.04, accounting for 12.24% of all new cancer cases and 25.26% of all cancer deaths occurring in young adults. The burden was disproportionally greater among males, with male: female ratios of 1.34 for incidence and 1.58 for mortality. The ASIRs were 2.1, 1.4, and 1.0 per 100000 people per year, whereas the ASMRs were 0.83, 1.1, and 0.62 per 100000 people per year for colorectal, liver, and gastric cancer, respectively. When assessed by geographical region and HDI levels, the cancer profile varied substantially, and a strong positive correlation between the mortality-to-incidence ratio of digestive cancer and HDI ranking was found ( R 2 = 0.7388, P < 0.001). CONCLUSION The most common digestive cancer types are colorectal, liver and gastric cancer. The global digestive cancer burden among young adults is greater among males and exhibits a positive association with socioeconomic status. The digestive cancer burden is heavy in young adults, reinforcing the need for primary and secondary prevention strategies.

Comparative Analysis of Clinical Efficacy between Laparoscopic Assisted Radical Gastrectomy and Open Surgery in the Treatment of Advanced Gastric Cancer

“…Gastric cancer is a common malignant tumor of digestive system in clinic. In recent years, with the changes of people's living habits and dietary structure, the incidence rate of gastric cancer continues to rise [7]. According to the data of China National Cancer Center in 2019, the incidence rate and mortality of gastric cancer ranked second and third among all malignant tumors respectively.…”

The Rise of Gastrointestinal Cancers as a Global Phenomenon: Unhealthy Behavior or Progress?

“…Even though the prognosis of GI cancers, in general, could be better among younger patients, the overall burden is greater, and the outcome can be worse than those of non-GI cancers [ 1 ]. The burden of GI cancers can be very significant in young patients given that they have a long life expectancy and constitute the major contributors to the economy and family support [ 10 ].…”

Global burden of 34 cancers among women in 2020 and projections to 2040: Population‐based data from 185 countries/territories

“…[15][16][17][18][19][20] Previous studies focusing on the MIR of cancer addressed specific cancer types in limited countries and in certain age groups of women, 17,18,23 for example, assessing only digestive cancer types 17,23 or focusing on adolescents and young adults (AYA). 23 Such specificity in estimating the MIR of cancer is unlikely to provide comprehensive worldwide evidence on cancer affecting women, creating an evidence lacuna for policy and decision-making to improve cancer outcomes among women. Thus, there is a need for evidence on the MIR of cancer among women overall and among selected age groups, such as AYA, as well as by menopausal status.…”